Inspire Investing LLC reduced its stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 37.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,806 shares of the company's stock after selling 3,423 shares during the period. Inspire Investing LLC's holdings in Molina Healthcare were worth $1,912,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently made changes to their positions in the stock. Amalgamated Bank boosted its stake in shares of Molina Healthcare by 0.3% in the 1st quarter. Amalgamated Bank now owns 11,580 shares of the company's stock valued at $3,814,000 after purchasing an additional 33 shares in the last quarter. Deseret Mutual Benefit Administrators boosted its stake in shares of Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock valued at $30,000 after purchasing an additional 34 shares in the last quarter. JLB & Associates Inc. boosted its stake in shares of Molina Healthcare by 0.3% in the 1st quarter. JLB & Associates Inc. now owns 10,626 shares of the company's stock valued at $3,500,000 after purchasing an additional 36 shares in the last quarter. PenderFund Capital Management Ltd. boosted its stake in shares of Molina Healthcare by 0.4% in the 1st quarter. PenderFund Capital Management Ltd. now owns 10,071 shares of the company's stock valued at $3,317,000 after purchasing an additional 40 shares in the last quarter. Finally, Rothschild Investment LLC boosted its stake in shares of Molina Healthcare by 126.3% in the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock valued at $28,000 after purchasing an additional 48 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Molina Healthcare Stock Down 4.2%
NYSE:MOH opened at $180.59 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66. Molina Healthcare, Inc has a one year low of $151.95 and a one year high of $365.23. The firm's 50 day simple moving average is $179.44 and its 200 day simple moving average is $266.19. The company has a market cap of $9.79 billion, a PE ratio of 8.90 and a beta of 0.54.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The firm had revenue of $11.43 billion for the quarter, compared to the consensus estimate of $10.94 billion. During the same quarter in the previous year, the business posted $5.86 EPS. The firm's revenue for the quarter was up 15.7% compared to the same quarter last year. On average, research analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.
Insider Activity at Molina Healthcare
In other Molina Healthcare news, Director Ronna Romney sold 700 shares of the firm's stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the transaction, the director owned 17,131 shares in the company, valued at approximately $2,633,719.94. This trade represents a 3.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO James Woys purchased 10,000 shares of the stock in a transaction on Monday, August 4th. The shares were purchased at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the acquisition, the chief operating officer owned 74,331 shares in the company, valued at approximately $11,591,176.14. The trade was a 15.54% increase in their position. The disclosure for this purchase can be found here. 1.10% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on MOH shares. Wall Street Zen downgraded shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Sanford C. Bernstein cut their target price on shares of Molina Healthcare from $284.00 to $220.00 and set an "outperform" rating on the stock in a research report on Friday, September 5th. JPMorgan Chase & Co. cut their target price on shares of Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating on the stock in a research report on Tuesday, July 29th. Wells Fargo & Company cut their target price on shares of Molina Healthcare from $216.00 to $198.00 and set an "overweight" rating on the stock in a research report on Friday, August 15th. Finally, UBS Group cut their target price on shares of Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Three equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat.com, Molina Healthcare has an average rating of "Hold" and an average target price of $225.18.
View Our Latest Stock Analysis on Molina Healthcare
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.